HeimGEHC • NASDAQ
add
GE HealthCare Technologies Inc
76,44 $
Eftir lokun(0,00%)0,00
76,44 $
Lokað: 12. sep., 16:30:59 GMT-4 · USD · NASDAQ · Lagalegir fyrirvarar
Við síðustu lokun
77,96 $
Dagbil
76,38 $ - 77,64 $
Árabil
57,65 $ - 94,80 $
Markaðsvirði
34,90 ma. USD
Meðalmagn
3,43 m.
V/H-hlutf.
15,65
A/V-hlutfall
0,18%
Aðalkauphöll
NASDAQ
Í fréttum
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
(USD) | jún. 2025info | Breyting á/á |
---|---|---|
Tekjur | 5,01 ma. | 3,47% |
Rekstrarkostnaður | 1,25 ma. | -2,87% |
Nettótekjur | 486,00 m. | 13,55% |
Hagnaðarhlutfall | 9,71 | 9,84% |
Hagnaður á hvern hlut | 1,06 | 6,00% |
EBITDA | 880,00 m. | 2,09% |
Virkt skatthlutfall | 18,43% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
(USD) | jún. 2025info | Breyting á/á |
---|---|---|
Reiðufé og skammtímafjárfestingar | 3,74 ma. | 87,04% |
Heildareignir | 35,50 ma. | 11,45% |
Heildarskuldir | 25,55 ma. | 7,08% |
Eigið fé alls | 9,95 ma. | — |
Útistandandi hlutabréf | 456,56 m. | — |
Eiginfjárgengi | 3,67 | — |
Arðsemi eigna | 5,30% | — |
Ávöxtun eigin fjár | 9,32% | — |
Peningaflæði
Breyting á handbæru fé
(USD) | jún. 2025info | Breyting á/á |
---|---|---|
Nettótekjur | 486,00 m. | 13,55% |
Handbært fé frá rekstri | 94,00 m. | 178,99% |
Reiðufé frá fjárfestingum | -223,00 m. | 36,10% |
Reiðufé frá fjármögnun | 1,36 ma. | 2.487,72% |
Breyting á handbæru fé | 1,29 ma. | 335,83% |
Frjálst peningaflæði | -80,00 m. | 8,57% |
Um
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures contrast agents and radiopharmaceuticals.
The company's primary customers are hospitals and health networks. In 2023, the company received 42% of its revenue in the United States and 13% of its revenue from China, where the company faces increasing competition.
The company operates in more than 100 countries. GE Healthcare has major regional operations in Buc, France; Helsinki, Finland; Kraków, Poland; Budapest, Hungary; Yizhuang, China; Hino & Tokyo, Japan, and Bangalore, India. Its biggest R&D center is in Bangalore, India, built at a cost of $50 million. Wikipedia
Framkvæmdastjóri
Stofnsett
1994
Höfuðstöðvar
Vefsvæði
Starfsfólk
53.000